AB-Biotics S.A.

https://www.ab-biotics.com

AB-BIOTICS is a Spanish biotechnology company focused on research, development, protection and distribution of its own exclusive biotechnological solutions. Since 2010, the company has been listed on the Spanish Alternative Investment Market (MAB). In December 2011, AB-BIOTICS closed a fundraising round of 4.3 million euros to tackle the 1st phase of the company's internationalization plan. The goal is to have presence in markets such as Brazil, USA, Mexico, UK, Germany, France and Turkey, especially to market its personalized medicine solutions and licensing its line of functional ingredients, including AB-LIFE. AB-Biotics' total revenue for 2011 was €6.16 million, up 71% from the previous year. *

	Start	2004-01-01 existent
	Industry	BIOTECH
	Person	Bonachera, Miquel Àngel (AB-Biotics 201202 CEO + co-founder)

	Region	Barcelona
	Country	Spain (España)
	Street	P1m1.1 Edifici Eureka Campus UAB
	City	08193 Bellaterra (Barcelona)
	Tel	+34-972-183-421
		Address record changed: 2024-01-05

Basic data	Employees	C: 51 to 100 (2011-08-29)
	Currency	EUR
	Annual sales	6,160,000 (revenue, total (2011) 2011-12-31)

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]